Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | -96.36%225.22K | -72.59%1.97M | -72.59%1.97M | 56.06%6.19M | 1,410.82%7.18M | 1,410.82%7.18M | 653.22%3.97M | -19.69%475.05K | -19.69%475.05K | -9.41%526.7K |
| -Cash and cash equivalents | -96.36%225.22K | -72.59%1.97M | -72.59%1.97M | 56.06%6.19M | 1,410.82%7.18M | 1,410.82%7.18M | 653.22%3.97M | -19.69%475.05K | -19.69%475.05K | -9.41%526.7K |
| -Available for sale securities | 29.94%505.54M | 18.43%463.95M | 18.43%463.95M | 5.63%389.06M | 12.27%391.76M | 12.27%391.76M | 17.71%368.31M | -4.91%348.95M | -4.91%348.95M | -7.78%312.9M |
| Receivables | 2.37%1.63M | -0.29%1.68M | -0.29%1.68M | -2.67%1.59M | 13.36%1.69M | 13.36%1.69M | 30.86%1.63M | -20.42%1.49M | -20.42%1.49M | 18.37%1.25M |
| Prepaid assets | -65.10%39.54K | 15.92%122.51K | 15.92%122.51K | 1.20%113.3K | 253.13%105.68K | 253.13%105.68K | 39.75%111.95K | -10.57%29.93K | -10.57%29.93K | 30.77%80.11K |
| Other assets | ---- | ---- | ---- | ---- | --155.88K | --155.88K | ---- | ---- | ---- | -70.60%52K |
| Total assets | 27.83%507.43M | 16.67%467.72M | 16.67%467.72M | 6.13%396.95M | 14.23%400.88M | 14.23%400.88M | 18.81%374.02M | -5.01%350.94M | -5.01%350.94M | -7.73%314.81M |
| Liabilities | ||||||||||
| Derivative product liabilities | -48.33%297.05K | -81.96%151.02K | -81.96%151.02K | 284.21%574.87K | 122.76%837.01K | 122.76%837.01K | -56.35%149.62K | 1,013.00%375.74K | 1,013.00%375.74K | 306.66%342.79K |
| Payables | 5.72%6.12M | 3.84%5.75M | 3.84%5.75M | 8.03%5.79M | 24.63%5.54M | 24.63%5.54M | 44.56%5.36M | 21.13%4.44M | 21.13%4.44M | 21.97%3.71M |
| -Accounts payable | 5.72%6.12M | 3.84%5.75M | 3.84%5.75M | 8.03%5.79M | 24.63%5.54M | 24.63%5.54M | 44.56%5.36M | 21.13%4.44M | 21.13%4.44M | 21.97%3.71M |
| Other liabilities | 5.97%231.33M | 5.24%222.91M | 5.24%222.91M | 9.21%218.29M | 16.82%211.81M | 16.82%211.81M | 26.34%199.89M | 14.68%181.31M | 14.68%181.31M | 17.05%158.21M |
| Total liabilities | 5.82%237.75M | 4.87%228.81M | 4.87%228.81M | 9.38%224.66M | 17.22%218.18M | 17.22%218.18M | 26.59%205.4M | 15.04%186.13M | 15.04%186.13M | 17.20%162.26M |
| Shareholders'equity | ||||||||||
| Total stockholders'equity | 56.53%269.68M | 30.76%238.9M | 30.76%238.9M | 2.17%172.29M | 10.85%182.7M | 10.85%182.7M | 10.54%168.62M | -20.63%164.81M | -20.63%164.81M | -24.75%152.55M |
| Total equity | 56.53%269.68M | 30.76%238.9M | 30.76%238.9M | 2.17%172.29M | 10.85%182.7M | 10.85%182.7M | 10.54%168.62M | -20.63%164.81M | -20.63%164.81M | -24.75%152.55M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.